246 related articles for article (PubMed ID: 26936091)
1. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer.
Duan J; Sun L; Huang H; Wu Z; Wang L; Liao W
Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase is a prognostic marker and associated with immune infiltrating in gastric cancers precision medicine.
Zhou Y; Su W; Liu H; Chen T; Höti N; Pei H; Zhu H
Biomark Med; 2020 Feb; 14(3):185-199. PubMed ID: 31904263
[No Abstract] [Full Text] [Related]
3. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fatty Acid Synthase Negatively Correlates with PTEN and Predicts Peritoneal Dissemination of Human Gastric Cancer.
Xiang HG; Hao J; Zhang WJ; Lu WJ; Dong P; Liu YB; Chen L
Asian Pac J Cancer Prev; 2015; 16(16):6851-5. PubMed ID: 26514456
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
8. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
10. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
13. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of miR-141 downregulation in gastric cancer.
Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
[TBL] [Abstract][Full Text] [Related]
17. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
18. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]